Several names side by side, grouped by industry, each with a dated development we can point to. These are watchlists — starting points for your own work. They are not recommendations, and they carry no price targets.
Four supplement microcaps ended the June quarter with no bank debt. What the cash sits beside differs in each.
Five US-listed microcaps drawing federal grants, loans and contracts. Non-dilutive money is real validation and rarely…
Five US-listed companies whose annual revenue exceeds their market value six to sixteen times over. That gap is a…
Four US-listed banks under $500M, screened for tradability first. Most of the sector failed before we read a single…
Four US-listed microcaps that pull things out of the ground, process them or ship them. Screened for liquidity first…
Five applied-AI and edge-infrastructure microcaps, each with a dated development in the last eight weeks. A watchlist…